Erratum: Corrigendum to “Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice” (Atherosclerosis (2015) 243(2) (598–608) (S0021915015301805) (10.1016/j.atherosclerosis.2015.10.096))

Abstract

The authors regret the published article contains an error in the quantification of the lysophospholipid species. The relative levels of sn-1 and sn-2 LPC and LPE in both plasma and heart of the untreated and BA-treated animals were misrepresented in Fig. 2. A correct version of Fig. 2 is now provided. The changes in the figure have not altered the interpretation in the manuscript with respect to the atherosclerosis outcome or to the increase in sn-2 LPC in the BA-treated animals that was likely due to the oxidation of plasmalogen. Rather, this figure provides a more accurate representation of the relative level of sn-1 and sn-2 species of LPC and LPE in plasma and heart. Further, in section..